Vaccine developed at University of Houston to end fentanyl overdoses headed for human clinical trials

Vaccine developed at University of Houston to end fentanyl overdoses headed for human clinical trials

HOUSTON – A vaccine that was developed at the University of Houston to prevent fentanyl deaths has been licensed by a new medical startup and will head for human clinical trials, according the the university.

OVAX Inc. raised $10 million to commercialize research from the lab of Colin Haile, a…

[ad_2]

Source link

More From Author

Call for papers – Translating the microbiome in health and disease

Call for papers – Translating the microbiome in health and disease

Doctors hail breakthrough in fight against Parkinson’s: Treatment developed by Scots university hailed as a ‘miracle’ by patient in trial

Leave a Reply

Your email address will not be published. Required fields are marked *

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.